4.7 Review

Botulinum Toxin Treatment of Motor Disorders in Parkinson Disease-A Systematic Review

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Prevalence of axial postural abnormalities and their subtypes in Parkinson's disease: a systematic review and meta-analysis

Shuangshuang Cao et al.

Summary: This study conducted a systematic review and meta-analysis to investigate the prevalence of axial postural abnormalities in Parkinson's disease (PD). The results showed that axial postural abnormalities, including scoliosis, camptocormia, Pisa syndrome, and antecollis, are not uncommon in PD patients. These abnormalities are associated with older age, longer disease duration, and more severe motor symptoms.

JOURNAL OF NEUROLOGY (2023)

Editorial Material Clinical Neurology

Editorial: Tremors

Daniel Truong et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2022)

Editorial Material Clinical Neurology

Effects of Onabotulinum Toxin A on Gait in Parkinson's Disease Patients with Foot Dystonia

Pei Huang et al.

Summary: This study investigated the effects of botulinum toxin on gait in Parkinson's disease patients with foot dystonia. The results showed that botulinum toxin improved the severity of dystonia, reduced pain, and improved foot pressures during walking.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2022)

Article Clinical Neurology

Magnetic Resonance-Guided Focused Ultrasound Thalamotomy May Spare Dopaminergic Therapy in Early-Stage Tremor-Dominant Parkinson's Disease: A Pilot Study

Nico Golfre Andreasi et al.

Summary: This study compared the efficacy of MRgFUS thalamotomy and oral dopaminergic therapy in patients with early-stage tremor-dominant PD and found that MRgFUS thalamotomy can reduce tremor and prevent the need for increased dopaminergic medication.

MOVEMENT DISORDERS (2022)

Article Clinical Neurology

Diagnostic and therapeutic recommendations in adult dystonia: a joint document by the Italian Society of Neurology, the Italian Academy for the Study of Parkinson's Disease and Movement Disorders, and the Italian Network on Botulinum Toxin

Marcello Romano et al.

Summary: This paper outlines diagnostic and therapeutic recommendations for dystonia provided by a panel of Italian experts. It covers clinical methods and instrumental assessment, pharmacological, surgical and rehabilitative options, and a hospital-territory network model.

NEUROLOGICAL SCIENCES (2022)

Article Food Science & Technology

Real-World Longitudinal Experience of Botulinum Toxin Therapy for Parkinson and Essential Tremor

Olivia Samotus et al.

Summary: Kinematic-based injections of BoNT-A produced similar treatment outcomes to injections based on clinical expertise. This suggests that non-experts can use kinematic methods to achieve equivalent efficacy, potentially improving access to this treatment.

TOXINS (2022)

Review Neurosciences

Future Therapeutic Strategies for Freezing of Gait in Parkinson's Disease

Cathy K. Cui et al.

Summary: Freezing of gait is a common and challenging clinical symptom in Parkinson's disease. Developing individualized and on-demand therapies through improved detection and wearable technologies, as well as an integrated collaborative research approach, are essential for investigating new therapeutic avenues for effective treatment.

FRONTIERS IN HUMAN NEUROSCIENCE (2021)

Review Food Science & Technology

Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal

Wolfgang H. Jost

Summary: Botulinum neurotoxin (BoNT) has been used for a wide range of indications in patients with Parkinson's syndrome, with approved indications including sialorrhea, cervical dystonia, and blepharospasm, while other indications like tremor and hyperhidrosis still lack sufficient data support.

TOXINS (2021)

Article Clinical Neurology

Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity

Dirk Dressler et al.

Summary: Botulinum toxin (BT) therapy is a highly individualized and complex treatment that requires treatment algorithms and injection schemes to be tailored to each patient. Consensus guidelines have been updated and improved by acknowledging recent advances in treatment algorithms and providing more detailed dosing data. Collaborating with an international panel of experts has further enhanced the guidelines for BT therapy.

JOURNAL OF NEURAL TRANSMISSION (2021)

Editorial Material Clinical Neurology

Is Adult-Onset Dystonia a Rare Disease? Time for Population-Based Studies

Giovanni Defazio et al.

MOVEMENT DISORDERS (2021)

Review Clinical Neurology

Prevalence of freezing of gait in Parkinson's disease: a systematic review and meta-analysis

Wei-Shan Zhang et al.

Summary: Freezing of gait (FOG) is a common and underreported symptom in Parkinson's disease. Using specialized FOG assessment tools can provide a more accurate estimate of FOG prevalence in PD patients, which is often underestimated in hospital settings.

JOURNAL OF NEUROLOGY (2021)

Article Pharmacology & Pharmacy

Evidence for central antispastic effect of botulinum toxin type A

Ivica Matak

BRITISH JOURNAL OF PHARMACOLOGY (2020)

Editorial Material Clinical Neurology

Freezing of Gait and Its Levodopa Paradox

Jorik Nonnekes et al.

JAMA NEUROLOGY (2020)

Article Clinical Neurology

Prevalence and Relationship of Rest Tremor and Action Tremor in Parkinson's Disease

Deepak K. Gupta et al.

TREMOR AND OTHER HYPERKINETIC MOVEMENTS (2020)

Article Clinical Neurology

Standardized algorithm for muscle selection and dosing of botulinum toxin for Parkinson tremor using kinematic analysis

Olivia Samotus et al.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2020)

Article Clinical Neurology

Use of botulinum toxin in Parkinson's disease

Angeline Jocson et al.

PARKINSONISM & RELATED DISORDERS (2019)

Article Clinical Neurology

Incobotulinum toxin A in Parkinson's disease with foot dystonia: A double blind randomized trial

Isabelle Rieu et al.

PARKINSONISM & RELATED DISORDERS (2018)

Article Clinical Neurology

A prospective study of falls in relation to freezing of gait and response fluctuations in Parkinson's disease

Yasuyuki Okuma et al.

PARKINSONISM & RELATED DISORDERS (2018)

Article Food Science & Technology

Botulinum Toxin for the Treatment of Hand Tremor

Nicki Niemann et al.

TOXINS (2018)

Article Clinical Neurology

Botulinum Toxin Type A Injections as Monotherapy for Upper Limb Essential Tremor Using Kinematics

Olivia Samotus et al.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2018)

Article Clinical Neurology

Epidemiology of Parkinson's disease

Ole-Bjorn Tysnes et al.

JOURNAL OF NEURAL TRANSMISSION (2017)

Review Clinical Neurology

Botulinum Toxin: State of the Art

Joseph Jankovic

MOVEMENT DISORDERS (2017)

Review Clinical Neurology

Botulinum Toxin Therapy for Parkinson's Disease

Aparna Wagle Shukla et al.

SEMINARS IN NEUROLOGY (2017)

Article Clinical Neurology

More Time with Tremor: The Experience of Essential Tremor Versus Parkinson's Disease Patients

Elan D. Louis

MOVEMENT DISORDERS CLINICAL PRACTICE (2016)

Article Clinical Neurology

Freezing of gait: a practical approach to management

Jorik Nonnekes et al.

LANCET NEUROLOGY (2015)

Review Clinical Neurology

MDS clinical diagnostic criteria for Parkinson's disease

Ronald B. Postuma et al.

MOVEMENT DISORDERS (2015)

Article Clinical Neurology

Levodopa-carbidopa intrajejunal gel in advanced Parkinson disease with on freezing of gait

Giovanni Cossu et al.

NEUROLOGICAL SCIENCES (2015)

Article Clinical Neurology

A 12-year population-based study of freezing of gait in Parkinson's disease

E. B. Forsaa et al.

PARKINSONISM & RELATED DISORDERS (2015)

Article Clinical Neurology

The major impact of freezing of gait on quality of life in Parkinson's disease

Courtney C. Walton et al.

JOURNAL OF NEUROLOGY (2015)

Article Clinical Neurology

Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study

S. Vercruysse et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)

Article Multidisciplinary Sciences

Does Anxiety Cause Freezing of Gait in Parkinson's Disease?

Kaylena A. Ehgoetz Martens et al.

PLOS ONE (2014)

Article Clinical Neurology

Prevalence, Determinants, and Effect on Quality of Life of Freezing of Gait in Parkinson Disease

Santiago Perez-Lloret et al.

JAMA NEUROLOGY (2014)

Review Clinical Neurology

Phenomenology and classification of dystonia: A consensus update

Alberto Albanese et al.

MOVEMENT DISORDERS (2013)

Article Clinical Neurology

Levodopa changes the severity of freezing in Parkinson's disease

Urban M. Fietzek et al.

PARKINSONISM & RELATED DISORDERS (2013)

Review Clinical Neurology

Freezing of gait: moving forward on a mysterious clinical phenomenon

John G. Nutt et al.

LANCET NEUROLOGY (2011)

Article Clinical Neurology

Dystonia in Parkinson's disease

Eduardo Tolosa et al.

JOURNAL OF NEUROLOGY (2006)

Article Clinical Neurology

Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease

JD Schaafsma et al.

EUROPEAN JOURNAL OF NEUROLOGY (2003)

Article Clinical Neurology

Freezing of gait in patients with advanced Parkinson's disease

N Giladi et al.

JOURNAL OF NEURAL TRANSMISSION (2001)